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KEBOLEHLAKSANAAN MENGGUNAKAN FILEM RADIOKROMIK EBT2 
DAN MOSFET UNTUK PENGUKURAN DOS RADIOTERAPI DALAM 
RAWATAN KANSER NASOFARINKS 
ABSTRAK 
 Isipadu tumor Kanser Nasofarinks terletak di kepala dan leher dan berdekatan 
dengan pelbagai organ yang berisiko. Dengan itu, verifikasi dos radioterapi sebelum 
rawatan adalah langkah yang sangat penting. Ini memastikan dos yang mencukupi 
diberi ke isipadu tumor di samping melindungi organ yang berisiko. Pencirian respon 
dosimetri bagi kedua-dua Metal Oxide Semiconductor Field Effect Transistor 
(MOSFET) dan filem radiokromik EBT2 telah dijalankan sebelum mengendalikan 
verifikasi dos bagi rawatan radioterapi. Pencirian filem radiokromik EBT2 telah 
dijalani melalui beberapa ujian dan menyumbang 5.05% combined standard 
uncertainty. Ujian-ujian tersebut adalah kebolehulangan filem (0.25%), kesan 
kegelapan filem (0.25%), pergantungan saiz medan (4.98%), dan pergantungan sudut 
(2.01%). Tujuh eksperimen telah dijalani dan menyumbang 3.48% combined 
standard uncertainty bagi MOSFET. Eksperimen-eksperimen tersebut adalah 
kebolehulangan MOSFET (1.36%), kesan kepudaran filem (2.00%), perturbation 
(2.58%), lineariti (2.88%), pergantungan saiz medan (2.90%), pergantungan sudut 
(3.36%), pergantungan SSD (2.59%). Selepas ujian pencirian filem radiokromik 
EBT2 dan MOSFET, verifikasi dos bagi pelan radioterapi telah dijalankan secara in 
vitro. Ini menunjukkan bahawa dos yang diukur adalah lebih tinggi daripada dos 
yang dikira melalui Treatment Planning System (TPS). Dos TPS menunjukkan 
bahawa kedua-dua dosimeter berada dalam variasi 10%. Dengan ini, filem 
radiokromik EBT2 dan MOSFET adalah bersesuaian digunakan sebagai dosimeter 
dalam bidang radioterapi. 
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FEASIBILITY OF USING EBT2 RADIOCHROMIC FILM AND MOSFET 
FOR RADIOTHERAPY DOSE MEASUREMENT IN NASOPHARYNX 
CANCER TREATMENT 
ABSTRACT 
Nasopharynx cancer (NPC)’s tumour volume located at the head and neck 
which nearby with bundles of organ at risk (OAR). Therefore, it is important to have 
radiotherapy dose verification prior to the treatment. This is to make sure adequate 
dose delivered to tumour volume whereas protect well to organ at risk. Dosimetry 
response of both Metal Oxide Semiconductor Field Effect Transistor (MOSFET) and 
Radiochromic EBT2 film were characterised before the dose verification of 
radiotherapy treatment was conducted. The characterisation of Radiochromic EBT2 
film was ruled out from the tests which contributed combined standard uncertainty 
5.05%. Tests are film reproducibility (0.25%), film darkening effect (0.25%), field 
size dependence (4.98%), and angular dependence (2.01%). Seven experiments were 
undergone to contribute 3.48% combined standard uncertainty for MOSFET. The 
experiments are MOSFET reproducibility (1.36%), fading effect (2.00%), 
perturbation (2.58%), linearity (2.88%), field size dependence (2.90%), angular 
dependence (3.36%), SSD dependence (2.59%). After the characterisation of 
Radiochromic EBT2 film and MOSFET, treatment plan dose verification was 
conducted in vitro. It showed a trend that measured doses higher than calculated 
doses by Treatment Planning System (TPS). TPS doses verified both dosimeters 
doses within 10% variation. Thus, both Radiochromic EBT2 film and MOSFET were 
suitable to be used as radiotherapy 
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CHAPTER 1 INTRODUCTION 
1.1 Overview 
Cancer is one of the top ten causes of hospitalization in both Ministry of Health 
(MOH) and private hospitals in Malaysia. Even more noteworthy is cancer incident 
in Malaysia increased from 32000 new cases in 2008 to about 37000 in 2012 
(International Agency for Research on Cancer (IARC), 2013). It is particularly worth 
mentioning that cancer has overtaken heart disease as the number one killer in the 
year 2014 based on the latest Health Facts 2014 which was released by MOH.  
For year 2007, National Cancer Registry (NCR) reported the five most common 
cancers among Malaysians were breast cancer (18.1%), head and neck cancer 
(13.2%), colorectal cancer (12.3%), respiratory system cancer (10.2%) and followed 
by cervix uteri cancer (4.6%). Head and neck cancer included nasopharynx, larynx, 
tongue, mouth, nose and sinuses, salivary gland, hypopharynx, other oropharynx, 
tonsil, pharynx unspecified and lip. It was then followed by other cancers (41.6%) 
like lymphoma, leukemia, stomach, liver, prostate, bladder, nervous systems and 
others. 
Nasopharynx cancer (NPC) is the most common head and neck cancer among 
Malaysians. NCR 2007 reported that Chinese had the highest percentage (68.36%) of 
NPC incident, followed by Malay (29.64%) and Indian (2.00%) (Figure 1.1). NCR 
also reported NPC had higher incident rate in male rather than in female (Figure 1.2). 
Surgery, radiotherapy and chemotherapy are used either alone or in combination for 
NPC treatment in Malaysian’s cancer management. Radiotherapy is the modality 
which treat the cancerous cell by external beams or internal beams (brachytherapy) 
using ionising radiation. It involved the use of photon in kilovoltage (kV) to 
megavoltage (MV)  range.  
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Figure 1.1 Nasopharynx cancer by major ethnicity, Malaysia 2007 (NCR, 2007). 
 
 
Figure 1.2 Nasopharynx cancer by sex, Malaysia 2007 (NCR, 2007) 
 
The goal of radiotherapy is to eradicate tumour cell while sparing the organs at risk 
(OAR) and nearby healthy tissues (Travis, 1989). Intensity Modulated Radiotherapy 
(IMRT) is an advanced treatment technique which can deliver significant high doses 
to tumour volume (TV) while sparing the surrounding normal tissue (Lee, Chuang et 
al., 2002) 
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Before started a radiotherapy treatment, a series of comprehensive Quality Assurance 
in Radiotherapy (QART) procedures was carried out for machine installation and 
calibration, source delivery and safety, operational procedures, clinical dosimetry 
and the whole treatment planning process is designed and implemented (IAEA 
TRS115, 1994). Quality control (QC) procedures should be followed before and 
during treatment. It is important to verify calculated doses and measured doses tally, 
especially for IMRT which is a highly complex technique. It is also crucial to 
confirm the accuracy and reproducibility of treatment delivery. 
Ionisation chamber (IC), semiconductor detector, thermoluminescent detector (TLD), 
radiochromic film and metal oxide semiconductor field effect transistor (MOSFET) 
were the devices which had been developed to improve the efficacy of radiotherapy 
verification test. Radiochromic film and MOSFET are two dimensional (2D) 
detectors and provides high spatial resolution of measured dose distribution which is 
crucial for head and neck radiotherapy dosimetry. 
QC of IMRT plan includes verification of absolute dose distribution at one or more 
points of interest (POI) as well as of 2D dose distributions in different plane in a 
water equivalent phantom. QC of IMRT is highly concerned on the dosimetry of TV 
and OAR.  
Radiotherapy treatment for NPC involves OARs, such as brainstem, bilateral eyes, 
bilateral parotids and oral cavity. Therefore, QC to verify TV and OARs doses are 
crucial before pressing the start button onto the linear accelerator (LINAC) control 
panel for treatment. 
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1.2 Problem Statements 
Conventional dosimeters such as IC, semiconductor detector and TLD often fail to 
meet the requirement to provide high spatial resolution of 2D dose distributions and 
absolute dose determination at POI. 
IC has difficulty to measure large dose gradient due to the size of chamber. TLD 
require time consuming calibration and post processing procedure (Chung, Lee et al., 
2009). 
Although radiochromic film required careful calibration and post processing 
procedures (Chung, Lee et al., 2009), it provides high spatial resolution of 2D dose 
distribution which is necessary for IMRT QC. Whereas, MOSFET is easy to use, 
small size, light weight, instant readout and reducing time for processing. In this 
study, MOSFET and Radiochromic EBT2 film were used as clinical dosimeters. 
 
1.3 Objectives 
1. To verify the exposed radiation dose of TV and OARs in conventional mid-
plane dose (MPD) plan and IMRT plan in NPC radiotherapy.  
2. To characterise both dosimeters, Radiochromic EBT2 film and MOSFET: 
a) Radiochromic EBT2 film characterisation included film orientation, film 
sensitivity to room light, film darkening effect, film water immersion 
effect, film reproducibility, dose dependence, field size dependence, 
angular dependence and percentage depth dose (PDD) calibration.  
b) Characterisation of MOSFET include MOSFET fading effect, 
reproducibility, dose perturbation, dose dependence and linearity, field 
size dependence, angular dependence, SSD dependence and PDD 
calibration. 
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1.4 Organization of Research 
To achieve the objectives, this research study was divided into five chapters. 
Chapter one describes the introduction of this research study. It consists of four parts, 
overview, problem statements, objectives and organization of research. 
Chapter two elaborates literature review on five major areas. It includes review of 
common dosimeters used in radiotherapy; historical review of radiochromic EBT2 
film, MOSFET, and others dosimeter like IC and TLD; in vivo dosimetry; and 
radiotherapy technique. 
Chapter three describes instrumentations and methodology used in this research. 
Instrumentations are Radiochromic EBT2 film, MOSFET, flatbed scanner, ImageJ 
software program, Mobile MOSFET dose verification system, phantoms (solid water 
phantom, customised acrylic head and neck phantom and hemi-cylindrical acrylic 
phantom), LINAC, Computed Tomography (CT) scanner, and CMS XiO treatment 
planning system, IC, electrometer, MOSFET build-up cap and beam directional shell 
(BDS). Whereas methodology included characterisation of scanner, radiochromic 
EBT2 Film and MOSFET, general characteristic as a dosimeter for Radiochromic 
film and MOSFET, calibration of MOSFET system and in vitro dose verification on 
a customised phantom. 
Chapter four describes the results and discussion of this research. 
Chapter five describes the conclusion of this research. Nevertheless, 
recommendations for future research are provided. 
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CHAPTER 2 LITERATURE REVIEW 
2.1 Common Dosimeters Used in Radiotherapy 
For the past few years, extensive research has been carried out to develop detectors 
for radiotherapy treatment verification, QC and QART check. Dosimeter is a detector 
that is able to measure absolute dose or unit to derive equivalent dose (Podgorsak, 
2003). Absolute dose is usually measured in Gray (Gy) which is equivalent to energy 
in joule that is being absorbed in human tissue per kilogram (Shapiro, 1990).  
Radiotherapy dosimetry can be measured in one dimension (1D), two dimensions 
(2D) and three dimensions (3D). 1D dosimetry is for a point dose measurement; 2D 
gives a dose distribution map; 3D is for target volume dose measurement. IC, 
semiconductor dosimeter, TLD, optical stimulated luminescence dosimeter (OSLD) 
and radiophotoluminescene (RPL) are the common 1D dosimeters used in 
radiotherapy field. Radiochromic film and MapCheck is the popular dosimeter used 
in 2D radiotherapy dosimetry. Cylindrical PRESAGE dosimeter, polymer gel and 
Frickle gel are the common 3D dose verification dosimeter (Guo, Adamovics et al. 
2006). 
 
2.2 Radiochromic EBT2 Film in Medical Physics 
Before Radiochromic films were introduced, radiographic films were used widely in 
diagnostic radiology. The latter films were designed primarily for detecting low 
energy (kilovoltage) radiation based on silver halide film technology of photographic 
industry. Radiochromic films were developed after this for quantitative dose 
measurements in megavoltage beams (radiotherapy in megavoltage (MV) energy). 
When the films are exposed to ionising radiation, the films change colour without 
dark room facility or film developer. In clinical and research for MV energy beams, 
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radiochromic films MD-55 with 50-100 Gy doses range were initially introduced, 
followed by models HD-810 and HS which were provided by International Specialty 
Products (ISP). However, low sensitivity prevented their routine use in 2D dose 
distribution measurements in clinical environment. Radiochromic film EBT 
(External Beam Therapy) followed by a newer version called EBT 2 was then 
introduced. IMRT verification becomes feasible with Radiochromic EBT 2 films in 
clinical application.  
 
2.3 MOSFET in Medical Physics 
The basic principle of transistor was first patterned by Julius Edgar Lilienfield in 
1925. After this, Dawon Kahng and Martin M. (J) Atalla invented the MOSFET as 
an offshoot to the patented field-effect transistor (FET) design in 1959. 
MOSFET was initially designed for monitoring radiation dose in the space. In the 
recent years, MOSFET is widely used for dose verification in medical radiation such 
as in therapeutic and diagnostic applications. Nowadays, MOSFET is frequently used 
in dose verification in radiotherapy for IMRT and beam Quality Assurance (QA) 
purpose. 
 
2.4 Other Dosimeters in Medical Physics 
Other than Radiochromic EBT2 film and MOSFET, IC and TLD are popular 
detectors among the choices of radiotherapy dosimetry.  
Development of radiation dosimetry is closely tied with IC. In 1908, Paul Villard 
proposed the use of IC connected to an electrometer (Frame 2005). In 1940, Frisch 
invented the gridded IC and hence gas-filled detector in late 1940 (Flakus F.N., 
1981). Nowadays, IC is the gold standard for absolute radiotherapy dosimetry. It is 
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recommended by International Atomic Energy Agency (IAEA) to use IC for 
determination in reference irradiation conditions which is named beam calibration. 
Due to different specific requirement during measurement, ICs are designed in 
various shapes and sizes. Cylindrical (thimble type) and parallel plate (plane-parallel) 
are the common IC used in radiotherapy dosimetry (Izewska J and Rajan G, 2010). 
IC is reusable and self reading for immediate determination of exposure. 
TLD has been used as 1D dosimeter in radiotherapy to measure the point dose over 
30 years. It is a popular dosimeter due to its small size, reusable, and can use in 
measurement for a wide range of radiotherapy energy. Due to lengthy annealing 
process of TLD, it cannot provide immediate readout. Thus TLD is time consuming 
and is not popular in recent decades (AAPM report No.87, 2005). 
 
2.5  In Vivo Dosimetry and In Vitro Dosimetry 
In Latin, in vivo is meant for “within living” and in vitro is meant for “in glass”. In 
vivo dosimetry measures the dose received by patients during the radiotherapy 
treatment; whereas in vitro dosimetry measure the dose received by the phantom 
which represent patients before or after the radiotherapy treatment (Mijnheer, 2008). 
Both in vivo and in vitro dosimetry play important role in radiotherapy QA especially 
during advanced radiotherapy techniques. It can prevent the potential errors in dose 
calculation, data transfer, dose delivery, patient setup, and others.  
In vivo and in vitro dosimetry can be done in two ways: the dosimeter invasively 
inserted into the patient or phantom at the POI, or the dosimeter non-invasively 
placed on the patient or phantom or at some distance with appropriate build up. 
American Association of Physicist in Medicine (AAPM) Report 87 has summarized 
a guideline for in vivo dosimetry in clinical routine. 
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2.6  Radiotherapy Techniques 
Radiotherapy is rapidly growing in this few eras since it is one of the beneficial 
option for malignant and benign diseases treatment (Slater, 2012). In 1954, the first 
treatment on human being, followed by first hospital-based proton facilities in mid 
1980s. A series of research is always ongoing to develop new techniques to destroy 
cancer cells yet minimizing dose to healthy tissue. 
LINAC was introduced in the 1960s. It produces high energy and deep penetration 
MV treatment. At the very first beginning, the simulation was done on-site marking 
followed by x-ray simulation and currently CT simulation by the rapidly advent of 
imaging technologies since 1970s. Nevertheless, computerized treatment planning 
technology was developed in the last quarter of 20
th
 century too (DeVita Jr and 
Rosenberg, 2012). It contributed to 3D conformal, IMRT and Image Guided 
Radiotherapy (IGRT) which can precisely match the tumour shapes by several 
directions using multiple shaped beams (Evolution of cancer treatments: Radiation, 
American cancer Society, 2014) (DeSantis, Lin et al., 2014)(Figure 2.1). With 
IMRT, each beam has modulated intensity of the radiation to deliver varying 
amounts of dose. These hundreds of “beamlets” are made possible by computer-
controlled multileave collimator (MLC) which are mounted inside the linear 
accelerator. These move continuously during the treatment to deliver varying doses 
of radiation within the field (Figure 2.2). An extensive planning process needs to be 
carried out in IMRT treatment.  
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Figure 2.1: Computer controlled multileaves collimators in IMRT 
(Source: Hand notes of IAEA Post Graduate Education Course in Radiation 
Protection and Safe Use of Radiation Sources). 
 
 
 
Figure 2.2: Modulated dose intensity by several beamlets in different beams’ 
position. 
(Source: Hand notes of IAEA Post Graduate Education Course in Radiation 
Protection and Safe Use of Radiation Sources). 
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2.7 In vitro Dose Verification on a Customised Acrylic (PERSPEX) Head and 
Neck Phantom 
2.7.1 Introduction 
The purpose of this research is to verify the measured delivered dose in radiotherapy 
to the treatment planned dose. This dose verification procedure was done on a 
customised acrylic (Perspex) head and neck phantom using two different 
measurement tools; Radiochromic EBT2 film and MOSFET. NPC (Figure 2.3) is the 
highest ranking among the head and neck cancer in Malaysian population especially 
Chinese population (The National Cancer Registry (NCR), 2011). Thus NPC cases 
were chosen in this study. Radiotherapy has four major procedures, which are 
simulation, radiotherapy planning, dose verification and radiotherapy delivery 
(Figure 2.4). 
  
(a)                 (b) 
 
Figure 2.3: Nasopharynx Cancer (NPC). (a) Illustration of NPC in human head 
anatomy (Source: NCR, 2011).   (b) Red contour showed NPC target volume in 
sagittal plane of CT images (Source: CMS XiO TPS). 
 
 
 
Figure 2.4: The radiotherapy standard procedures (Source: CMS XiO brochure). 
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2.7.2 Simulation 
In the very beginning for NPC radiotherapy, the oncologist will mark the desired 
treatment area on the patient’s skin by estimation from anatomical structure. With 
improvement in technology, NPC radiotherapy went from conventional simulation 
using a simulator named 2D treatment planning to CT simulation. The latter was 
named 3D treatment planning (Figure 2.5) and now even four-dimension (4D) 
treatment planning is a possibility (Barrett, Dobbs et al. 2009). In radiotherapy 
planning, it is crucial to have a comfortable positioning for patient for high 
reproducibility. An immobilization tool, for example a BDS, is commonly used in 
NPC radiotherapy to ensure high reproducibility of treatment (Figure 2.6). 
 
Figure 2.5: A brain cancer patient having a 3D simulation planning using CT 
scanner, with a head BDS (Source: Cancer Research UK).  
 
 
 
Figure 2.6: A customised head and neck BDS is molding onto a particular head and 
neck cancer patient (Picture taken at simulation room Pantai Hospital Penang). 
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2.7.3  Radiotherapy Planning 
Radiotherapy planning is the process of determining the best method of treating a 
tumour volume using high energy radiation (Stanton et al., 1996).  At Pantai Hospital 
Penang, the radiotherapy plans were done by computerized XiO Treatment Planning 
System (TPS). The main purpose of radiotherapy planning is to ensure tumour 
volume receives a uniform and adequate radiation dose whilst the healthy tissues and 
organs at risk are protected (Stanton et al., 1996). According to the International 
Commission on Radiation Units and Measurements 50 (ICRU 50, 1993) tumour 
volume can be categorized as gross target volume (GTV), clinical target volume 
(CTV) and planning target volume (PTV) (Figure 2.7). Oncologist will contour the 
target volume according to the above mentioned protocol and decide on the desired 
treatment dose. 
 
Figure 2.7: The illustration of ICRU 50 target volume definition.  
(Source: ICRU 50, 1993). 
 
The medical physicist will design a customised radiotherapy planning with 
appropriate radiation field arrangements. Lead block or MLC will enhance the 
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radiotherapy plan by shielding the organs at risk and healthy tissues from irradiation. 
Manual calculation of dosage or complex computerized planning will be the next 
step of radiotherapy planning. The types of radiotherapy plan can be categorized as 
single field, MPD, wedge-paired, multi-fields conformal and IMRT (Figure 2.8).  
 
Figure 2.8: Isodose lines for different types of radiotherapy plan; 2D radiotherapy 
plan, 3D radiotherapy plan and IMRT plan (Source: Lei Xing 2011). 
 
In this research, the dose verification of three radiotherapy plans planned by XiO 
TPS; MPD plan and two different seven fields IMRT plans were done on a 
customised acrylic head and neck phantom. 
 
2.7.3(a)   Mid-Plane Dose (MPD) Plan 
MPD plan is a parallel opposed field beam configuration (Stanton et al., 1996). This 
field arrangement is suited for treatment of midline structures. Since the human head 
is symmetrical and nasopharynx tumour is assumed to be located along the midline 
of the clivus bone, NPC can be treated with lateral MPD plan. This is done in some 
cancer centers. 
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2.7.3(b)   Intensity Modulated Radiotherapy (IMRT) Plan 
IMRT is an advanced conformal radiotherapy that utilizes computer optimized 
inverse treatment planning and computer controlled treatment delivery (Chuang et 
al., 2002). It is currently the most favoured choice for head and neck cancer 
radiotherapy, including NPC. This radiotherapy involves multiples beam angles and 
segments which have varied or modulated dose intensity (Figure 2.9). It is able to 
produce a customised radiation dose intensity to maximize the tumour dose while 
minimizing the dose to adjacent OAR and healthy tissues. 
  
(a)      (b) 
Figure 2.9: Illustration of an IMRT plan. (a) IMRT plan with multiple beam angles 
and modulated dose intensity. (b) MLC leaves formed non-uniform intensities to the 
beams. (Source: Lei Xing 2011). 
 
2.7.4 Dose Verification 
After treatment planning, the next procedure is dose verification prior to radiotherapy 
delivery. Since IMRT has high complexity dose patterns and techniques, QC should 
be done for both equipment operation and delivery of treatment to individual patients 
(Williams 2014). In Pantai Hospital Penang, for equipment operation wise, QC was 
done using MapCheck2 to check the dose map whereas for patient, portal film or 
electronic portal imaging (EPID) was taken before the start button was pressed. 
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Measurements on phantom where the human anatomy is reproduced are often 
recommended in addition to in vivo measurements (Cho et al., 2007). Therefore, a 
series of testing using in vitro measurement tools like Radiochromic EBT2 Film and 
MOSFET were performed on the phantom in this study. 
 
2.7.5 Radiotherapy Delivery 
In Pantai Hospital Penang, radiotherapy is delivered once the verification in dose and 
patient positioning passed the requirement. In normal cases, NPC radiotherapy is 
delivered over a total of 33 to 37 fractions with five fractions per week. 
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CHAPTER 3 INSTRUMENTATION AND METHODOLOGY 
3.1 Instrumentations 
3.1.1 Radiochromic EBT2 Film 
3.1.1(a)   Physical Properties of Radiochromic EBT2 Film 
Radiochromic EBT2 film is available in 8 x 10 inch and 14 x 17 inch sheets. The 
effective atomic number, Zeff, is calculated as 6.84. Radiochromic EBT2 Film is 
formed by polyester overlaminate (50 microns), pressure sensitive adhesive layer (25 
microns), active layer (28 microns) and polyester substrate (175 microns) (ISP, 
2009). Compared with Radiochromic EBT Film, the active part of the film has been 
reduced to a single layer. The structure is shown in Figure 3.1. 
 
Figure 3.1: Configuration of Radiochromic EBT2 film (Source: ISP, 2009). 
 
 
Figure 3.2: Method used to keep track of the film orientation (ISP, 2009). 
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This film incorporates a yellow marker dye which protects the active layer from 
exposure to ultraviolet and visible light. Besides, this yellow dye can be used as the 
baseline for the response. Later, a synthetic polymer replaced gelatin to make this 
film more tightly controlled from lot to lot for uniform response to radiation. 
Radiochromic EBT2 film is marked with a small slit to distinguish the sides. To let 
the 50 microns polyester laminate side face us, the slit must at the right side top edge 
and the film held in landscape orientation as shown in Figure 3.2. 
 
3.1.1(b)   Dosimetric Response of Radiochromic EBT2 Film 
Radiochromic EBT2 film uses the exactly same active component as the original 
version Radiochromic EBT but incorporates a yellow dye. Since this film is 
asymmetrical in its cross section with two different thicknesses of outer polyester 
layers, therefore, the side of film facing the scanner bed is important. The film has to 
be placed on the same side facing the scanner bed to get a consistent response 
especially when scanning in portrait orientation. 
Radiochromic EBT2 film gives a different response in different channels of the 
scanner. In the dose range from 1 cGy to 10 Gy (as done in this research), the red 
colour channel is the most suitable channel response. The green colour channel is 
suitable for measurements up to 40 Gy whereas the blue colour channel is used to 
adjust small response differences over the area of a film (ISP, 2009). 
 
3.1.1(c)   Advantages and Disadvantages of Radiochromic EBT2 Film 
Radiochromic EBT2 film can be easily cut to desired shape and size. It can be also 
immersed in water for hours and cleaned with water or alcohol; this makes it viable 
for use in a water phantom. This film has low sensitivity to light; therefore it is 
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convenient to handle in room light. It can develop in real time and also the density 
changes stabilize rapidly after exposure. 
One of the disadvantages of Radiochromic EBT2 film is that it is no longer possible 
to measure using blue channel response as the dye is yellow colour; it produces a 
strong signal in the blue channel. Therefore for doses more than 50 Gy it is not 
recommended to use the Radiochromic EBT2 film. However Radiochromic HD810 
film can be used for dose more than 50 Gy. Besides, Radiochromic EBT2 Film is 
slightly thicker compared with the original Radiochromic EBT film. 
 
3.1.2 Metal Oxide Semiconductor Field-Effect Transistor (MOSFET) 
3.1.2(a)   Physical Properties of MOSFET 
The physical size of standard MOSFET is 2.5 mm (width of flex) x 200 mm (length 
of flex) x 0.3 mm (thickness of flex). The MOSFET detector is coated by a thin 0.6 
mm layer black epoxy mounted on to the end of laminated polyamide cable, sized 
2.5 mm (width) x 3.5 mm (length) x 1 mm (thickness). Consequently, the mounted 
bubble side is referred as epoxy side and the opposite side is referred as flat side. The 
structure is shown in the Figure 3.3. 
  
Figure 3.3: Standard MOSFET system by BEST Medical Canada. 
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3.1.2(b)   Dosimetric Response of MOSFET 
The sensitive volume of MOSFET dosimeter is 0.2 mm x 0.2 mm cross sectional and 
0.5 µm thick (Ramaseshan, Kohli et al., 2004). 
MOSFET consists of a p-type silicon semiconductor substrate, a layer of insulating 
oxide and a metal gate (Kohno et al., 2008). A positive bias is applied between the 
gate and source terminals (+ 15 V and + 1 V) before irradiation (Ramasesham et al., 
2004) (Rosenfeld 2006). When irradiated, the ionising radiation generates electron 
hole pairs in the insulating layer and some holes drift toward the substrate under the 
appropriate bias voltage and then get trapped. A negative voltage is then applied 
between the gate and the source terminals after irradiation in the read state. 
 
3.1.2(c)   Advantages and Disadvantages of MOSFET 
The instantaneous reading and immediate reuse are the main advantages of the 
MOSFET. Using MOSFET to get the real time measurement can help to detect and 
correct the delivered dose before the radiation therapy is ended. Besides, its 
portability, small size, and no need cables to measure the signal by the detector make 
MOSFET a better choice. The negligible attenuation of radiation and low power 
requirement make MOSFET a good alternative in in-vivo dosimetry. Characteristics 
of MOSFET such as lightweight, flexible, ability to conduct multiple pinpoint dose 
measurement without patient shielding, and little sensitivity variation with 
temperature and dose readout (both direct dose and accumulated dose) are its other 
advantages. 
However, MOSFET’s limitation is that it has to be replaced when saturated. 
MOSFET is well-functioned when the accumulated dose less than 10000 mV; low 
dose performance degrades once accumulation dose equivalent achieved 17000 mV 
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(The Best Medical Canada Operator’s manual, 2010). If used, there is high noise 
drift at low dose; therefore, replacement is advised at the accumulated dose of more 
than 17000 mV. Besides, MOSFET shows slight field size dependence for 18 MV X-
ray (Ramaseshan et al. 2004). However this does not affect our research since only 6 
MV X-ray is used in this study. The manual recommends that the MOSFET reader 
should be on for 30 minutes prior to measurement for stable and reliable results (The 
Best Medical Canada Operator’s manual, 2010). 
 
3.1.3 Epson Expression 10000XL Scanner Film Dosimetry 
Epson Expression 10000XL scanner (Figure 3.4) is a professional colour flatbed 
scanner with A3 size scan bed. It is convenient for large-format scanning since it is 
possible to accommodate reflective media up to 12.2" x 17.2" or transparencies up to 
12.2" x 16.5". It has Micro Step Drive™ technology which gives brilliant clarity with 
detail. It has extraordinary image quality (2400 x 4800 dots per inch (dpi) resolution) 
and smooth gradations with 48-bit colour which captures over 4 trillion colours and 
4,096 shades of gray. The light source of this scanner is Xenon gas cold cathode 
fluorescent lamp. This Xenon lamp is an instant start lamp which makes it to be 
always in the ready status. The scanner is equipped with a linear CCD array detector 
and features a dual lens system. The system can be used in transmission or reflective 
mode, however, transmission mode is preferred for film dosimetry. The scanned 
images output formats are Joint Photographic Experts Group (JPEG), Bitmap image 
file(BMP), Tagged Image File Format (TIFF) and Portable Document Format (PDF). 
 
Figure 3.4: Epson Expression 10000XL scanner with transparent unit. 
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3.1.4 ImageJ software program and film analysis 
ImageJ is a free public domain software program used in image processing and 
analysis. It can display, edit and analyse various format images, including TIFF, GIF, 
JPEG, BMP, and DICOM. In this research, ImageJ was used to analyse the scanned 
Radiochromic EBT2 film. It allows extraction of 16 bits per channel (red, green and 
blue) from the 48 bits colour mode. This is the advantage of ImageJ which allows 
film pixel value reading by different colour channels, for example, red channel 
reading was used in Radiochromic EBT2 film analysis. For Radiochromic EBT2 film 
characterisation and analysis, scanned images in TIFF format were analysed using 
rectangular selection tools for area and pixel value calculation. Scale was set to 
analyse at the same region of interest (ROI) (1 cm x 1 cm) for the three repeated 
scans of each image. Therefore, 1 cm x 1 cm ROI was evenly cropped for pixel value 
calculation in RGB colour mode. The tool bar for ImageJ software program was 
shown in Figure 3.5. 
 
Figure 3.5: ImageJ tool bar. 
 
3.1.5 MobileMOSFET Dose Verification Systems 
MobileMOSFET Dose Verification System consist of Remote Monitoring Dose 
Verification Software which is installed in the computer, wall mounted Bluetooth
TM
 
Wireless Transceiver and an easy carry mobileMOSFET reader which act as a 
channel between MOSFET and the software. The MOSFETs are connected to 
mobileMOSFET Reader TN-RD-16 (SN: 00526 BEST Medical Canada). To obtain 
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measured dose in real time, mobileMOSFET reader will then interact with 
mobileMOSFET Dose Verification Software at the computer through the 
Bluetooth
TM
 Wireless Transceiver. This is user friendly and the seamless integrated 
system simplifies dosimetry. It also minimizes the QA time. Up to 40 MOSFETs can 
be read on-line with additional systems and transceivers. 
 
3.1.6 Phantom 
3.1.6(a)   Solid Water Phantom (White Polystyrene) 
White polystyrene solid water phantom (Figure 3.6) helps to eliminate the 
inconvenience of setting up and filling water tanks. The materials, epoxy resins and 
powders, are used to control the density and radiation properties. The main concern 
is the general density must be equivalent to the water density. Density of solid 
phantom used in this research is 1.04 g/cm
3
, which is considered water equivalent. 
Both PTW and RW3 solid phantoms had similar transmission values as compared to 
water to within ± 1.5% using gamma ray (140.5 keV) transmission measurement 
(R.F.Hill, 2007). Thickness of the solid water phantoms used in this research vary 
from 0.1 cm, 0.2 cm, 0.5 cm, 1 cm, 2 cm, 3 cm, 5 cm and 6 cm. These make it 
adequate to form various thicknesses in the calibration process.  
 
Figure 3.6: Solid water phantom made by white polystyrene in various thicknesses. 
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3.1.6(b)   Customised Acrylic (Perspex) Head and Neck Phantom 
A customised head and neck phantom was made using clear acrylic (Perspex). Clear 
acrylic is relatively cost effective compared to anthropomorphic human phantom. It 
has excellent durability for the phantom. The mass density of acrylic is relatively 
close to water density (1.0 gcm
-3
); that is 1.18 g/cm
3
. On the other hand, effective 
atomic number for acrylic is 6.48 whereas it is 7.42 for water. This phantom has 
similar density as human soft tissue in CT images. The difference of transmission 
value for acrylic is ± 4% compared to density of water (R.F.Hill, 2007).  
The head and neck phantom (Figure 3.7) was made using 1.0 cm thickness acrylic 
slab. A human’s head and neck CT slices were printed out in 1.0 cm slice thickness 
and then traced on the acrylic slab. Acrylic slabs were cut using electric hand cutter 
and polished to make the shape smooth. The cut acrylic slices were then stacked 
together using Germany adhesive double sided tape to ensure no air gaps remained in 
between the slabs. 
   
 
Figure 3.7: Customised Head and Neck Phantom using 1 cm slice of acrylic 
(Perspex). Both the front and side views are shown. 
 
 
 
